Design Therapeutics, Inc.’s DSGN share price has dipped by 5.42%, which has investors questioning if this is right time to ...

Sangamo Therapeutics, Inc.’s SGMO share price has surged by 10.12%, which has investors questioning if this is right time to sell.

1 Centre for Medical Image Computing, Department of Computer Science, University College London, Gower Street, London, UK 2 Huntington’s Disease Research Centre, University College London, 2nd Floor ...

AMT-130 is administered through magnetic resonance imaging-guided, convection-enhanced stereotactic neurosurgical delivery into the striatum.

A family with a rare genetic disease is bringing awareness to Siouxland. Deb Conley has Huntington’s Disease. According to ...

Qure's long-term success hinges on overcoming regulatory and logistical challenges. See why I rate QURE stock a hold.

The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to uniQure's AMT-130 for treating Huntington's disease, a rare neurodegenerative condition. This designation ...

FARGO — The Northern Plains Chapter of the Huntington's Disease Society of America will host a Team Hope Walk fundraiser and community-building event from 10 a.m. to noon May 3 at Rheault Farm ...

The US Food and Drug Administration (FDA) has awarded breakthrough therapy designation to uniQure's AMT-130 for treating ...

A drug originally developed for high blood pressure could find a new use in the treatment of Huntington's disease, thanks to an artificial intelligence-based drug discovery programme at Spain's ...